Yahoo Web Search

Search results

1. Moderna, Inc.

   NasdaqGS: MRNA

   65.69

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -2.33 (-3.43%)

   At close: Fri. Sep 20, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	67.60
     High	67.91
     Low	64.70

   • Mkt Cap	25.25B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	68.02
     52 Wk. Low	62.55
     52 Wk. High	170.47

   More about MRNA

   What analysts are saying

   Morningstar Bullish Published September 13 · Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was... Read more

   Top stories

   • MRNA
     -3.43%

   Jim Cramer Says Moderna Inc. (MRNA) ‘Has Been A Big Disappointment’

   Yahoo Finance · 24 hours ago

   

   • BNTX
     -0.20%
   • MRNA
     -3.43%

   ESMO 2024: Moderna’s mRNA solid tumour vaccine shows early promise

   Yahoo Finance · 1 week ago

   

   • MRNA
     -3.43%

   Jim Cramer Says Moderna, Inc. (MRNA)’s Vaccine Pipeline and Cancer Advances Make It a Strong Buy

   Yahoo Finance · 3 days ago

   

   Related stocks

   • NVAX
     Novavax, Inc.
     NVAX
     12.91
     +3.12%
   • BNTX
     BioNTech SE
     BNTX
     112.28
     -0.20%
   • ZM
     Zoom Video Communications, Inc.
     ZM
     67.53
     +0.93%
   • NIO
     NIO Inc.
     NIO
     5.28
     -2.22%
   • INO
     Inovio Pharmaceuticals, Inc.
     INO
     6.48
     -3.14%

   More on Yahoo Finance

2. finance.yahoo.com › quote › MRNAModerna, Inc. (MRNA) Latest Stock News & Headlines - Yahoo ...

   finance.yahoo.com › quote › MRNA

   • Cached

   Get the latest Moderna, Inc. (MRNA) stock news and headlines to help you in your trading and investing decisions.

3. People also ask

   Is Moderna (mRNA) a good stock to buy?

   • Recent positive results from trials for its Moderna, Inc. (NASDAQ:MRNA) based flu vaccine and new collaboration agreements highlight Moderna's commitment to leveraging its technology and expanding market opportunities, suggesting a bright future for the company. Overall MRNA ranks 9th on our list of Jim Cramer's must-watch stocks.

   Jim Cramer Says Moderna Inc. (MRNA) ‘Has Been A Big Disappointment’

   www.msn.com/en-us/money/markets/jim-cramer-says-moderna-inc-mrna-has-been-a-big-disappointment/ar-AA1qT4as

   See all results for this question

   Is mRNA a good investment?

   • Overall MRNA ranks 9th on our list of Jim Cramer's must-watch stocks. While we acknowledge the potential of MRNA as an investment, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe.

   Jim Cramer Says Moderna Inc. (MRNA) ‘Has Been A Big Disappointment’

   www.msn.com/en-us/money/markets/jim-cramer-says-moderna-inc-mrna-has-been-a-big-disappointment/ar-AA1qT4as

   See all results for this question

   How much will mRNA spend on R&D in 2025?

   • For 2025, MRNA expects R&D expenses to be between $4.2 billion and $4.5 billion. Management expects to start saving costs in 2027. It  anticipates R&D costs to be between $3.6 billion and $3.8 billion in the year. Moderna expects to generate revenues in the range of $2.5-$3.5 billion in 2025.

   Biotech Stock Roundup: GILD, NUVL Stocks Surge on Study Data, MRN…

   www.msn.com/en-us/money/markets/biotech-stock-roundup-gild-nuvl-stocks-surge-on-study-data-mrna-down-on-updates/ar-AA1qQpDL

   See all results for this question

   Why is Jim Cramer disappointed with Moderna Inc (mRNA)?

   • Jim Cramer expressed disappointment in Moderna Inc. (NASDAQ:MRNA), noting that despite having ample funding, the company has not delivered expected results. He believes they urgently need to develop a personalized vaccine to regain credibility and momentum. “MRNA has been a big disappointment.

   Jim Cramer Says Moderna Inc. (MRNA) ‘Has Been A Big Disappointment’

   www.msn.com/en-us/money/markets/jim-cramer-says-moderna-inc-mrna-has-been-a-big-disappointment/ar-AA1qT4as

   See all results for this question

4. finance.yahoo.com › quote › MRNAModerna, Inc. (MRNA) Stock Price, News, Quote & History ...

   finance.yahoo.com › quote › MRNA

   • Cached

   Find the latest Moderna, Inc. (MRNA) stock quote, history, news and other vital information to help you with your stock trading and investing.

5. Videos

   • 

     1:05

     youtube.com

     MRNA (Moderna stock) MRNA STOCK PREDICTIONS! MRNA STOCK Analysis mrna stock news today and mrna

     Aug 2, 2024

     206 Views

   • 

     0:43

     youtube.com

     Moderna, Inc. MRNA Stock Price Analysis Today

     Nov 9, 2023

   • 

     1:03

     youtube.com

     MRNA STOCK HUGE NEWS! (hurry!) MRNA stock trading broker review

     May 23, 2024

     96 Views

   View all

6. www.cnn.com › markets › stocksMRNA Stock Quote Price and Forecast | CNN

   www.cnn.com › markets › stocks

   • Cached

   3 days ago · View Moderna, Inc. MRNA stock quote prices, financial information, real-time forecasts, and company news from CNN.

7. stockanalysis.com › stocks › mrnaModerna, Inc. (MRNA) Stock Price, Quote & News - Stock Analysis

   stockanalysis.com › stocks › mrna

   • Cached

   4 days ago · Get a real-time Moderna, Inc. (MRNA) stock price quote with breaking news, financials, statistics, charts and more.

   • Market Cap: 29.45B
   • Revenue (ttm): 5.05B

   • Net Income (ttm): 5.87B
   • Shares Out: 384.40M

   • 
   • 
   • 
   • 

8. seekingalpha.com › symbol › MRNAModerna, Inc. (MRNA) Stock Price, Quote, News & Analysis

   seekingalpha.com › symbol › MRNA

   • Cached

   3 days ago · A high-level overview of Moderna, Inc. (MRNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

   • Company name: Biogen Inc.
   • Industry: Biotechnology

   • Employees: 7,570
   • Market Cap: 29.03B

9. www.google.com › finance › quoteModerna Inc (MRNA) Stock Price & News - Google Finance

   www.google.com › finance › quote

   • Cached

   Get the latest Moderna Inc (MRNA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

10. investors.modernatx.com › news › news-detailsModerna Expands the Field of mRNA Medicine with Positive ...

    investors.modernatx.com › news › news-details

    • Cached

    Sep 13, 2023 · Moderna's Triplet (mRNA-2752) is being evaluated in an ongoing Phase 1 study to evaluate safety and tolerability of mRNA-2752 administered alone and in combination with durvalumab, as well as an ongoing study evaluating mRNA-2752 in patients with ductal carcinoma in situ (DCIS).